Altogether, this inclusive analysis will shed light on the behavior of CDC20 in BC and evaluate the rationale of CDC20 inhibition as a potential therapeutic approach for treating BC patients with CDC20 overexpression. This evidence concerns the gene CDC20 and breast cancer.